<DOC>
	<DOCNO>NCT00580021</DOCNO>
	<brief_summary>Compare clinical characteristic post-surgical outcome ( overall survival ) pancreatic cancer patient Ashkenazi descent without germline founder mutation BRCA1 BRCA2 . Compare clinical characteristic outcome ( time progression ) breast cancer patient Ashkenazi descent without germline founder mutation BRCA1 BRCA2 receive paclitaxel chemotherapy metastatic disease .</brief_summary>
	<brief_title>Clinical Outcomes Hereditary Cancer</brief_title>
	<detailed_description>Compare clinical characteristic post-surgical outcome ( overall survival ) pancreatic cancer patient Ashkenazi descent without germline founder mutation BRCA1 BRCA2 . Compare clinical characteristic outcome ( time progression ) breast cancer patient Ashkenazi descent without germline founder mutation BRCA1 BRCA2 receive paclitaxel chemotherapy metastatic disease .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Included DB036303 Jewish religious preference registration Archival material available test Adequate postsurgical followup Jewish religious preference registration Archival material available test Adequate followup determine time progression Subjects include analysis DNA sample obtain .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Ashkenazi ancestry</keyword>
	<keyword>mutation BRCA1 BRCA2</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Pancreatic Cancer</keyword>
</DOC>